AI assistant
Sending…
PYC THERAPEUTICS LIMITED — Capital/Financing Update 2014
Jan 2, 2014
65640_rns_2014-01-02_24e34bbf-fd39-460d-a889-57708441a904.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [342 x 73] intentionally omitted <==
3[rd] January 2014
Market Announcements Platform Australian Securities Exchange
Dear Sir
Entitlement Issue Result and Shortfall
Phylogica Limited advises that the Entitlement Offer and Shortfall Offer has concluded with acceptances for 87% of the issue.
| acceptances for 87% of the issue. | ||
|---|---|---|
| Shares | % of issue | |
| EntitlementAcceptances | 233,849,306 | 58.3 |
| Shortfall Applications less than 1m shares | 31,664,802 | 7.9 |
| Shortfallapplications between 1mand 5mshares | 23,305,603 | 5.8 |
| Shortfall applications more than 5m shares | 60,011,803 | 15.0 |
| Underwriter commitment | 51,996,219 | 13.0 |
| Total issue | 400,827,733 | 100.0 |
Receipts from shareholders were $5,232,472.70.
The underwriter shortfall commitment amounts to $779,943.30.
Yours faithfully Phylogica Limited
==> picture [139 x 68] intentionally omitted <==
Graeme Boden
Company Secretary
PO Box 8207, Subiaco East, Western Australia 6008 Tel: +61 8 9384 3284 Fax: +61 8 9284 3801 www.phylogica.com ABN 48 098 391 961
More from PYC THERAPEUTICS LIMITED
Remuneration Information
2026
May 25
Investor Presentation
2026
May 21
Major Shareholding Notification
2026
May 17
Regulatory Filings
2026
May 11
Share Issue/Capital Change
2026
May 10
Regulatory Filings
2026
May 6
Investor Presentation
2026
May 3
Interim / Quarterly Report
2026
Apr 27
Share Issue/Capital Change
2026
Apr 27
Share Issue/Capital Change
2026
Apr 27